Exhibit 23.1



            CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



The Board of Directors
Synta Pharmaceuticals Corp.:


We consent to the use of our report dated January 27, 2006, with respect to
the consolidated balance sheets of Synta Pharmaceuticals Corp. as of December
31, 2005 and 2004, and the related consolidated statements of operations,
stockholders' equity (deficit) and comprehensive loss, and cash flows for
each of the years in the three-year period ended December 31, 2005 and the
period from inception (March 10, 2000) through December 31, 2005, included
herein and to the reference to our firm under the heading "Experts" in the
prospectus.


/s/ KPMG LLP


Boston, Massachusetts
December 1, 2006